Note. 2 Jun 2015.

Mylan tells Teva to ‘stop playing games’ Teva has bid $40bn for Mylan ©Bloomberg Mylan, a leading generics drugmaker, on Monday demanded that its rival Teva “stop playing games” and either turn its $40bn approach into a formal bid or walk away. Robert Coury, Mylan chairman, in a tersely worded letter attacked Israel’s Teva forContinue reading “Note. 2 Jun 2015.”